Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.

Vellore Karthikeyan, Deirdre Lane, David Beevers, Gregory Lip, Andrew Blann

Research output: Contribution to journalArticle

22 Citations (Scopus)


Matrix metalloproteinases (MMPs) are a family of endopeptidases that degrade the components of the extracellular matrix (ECM) such as collagen, and thus contribute to the remodelling and the physiological homeostasis of the ECM and its blood supply. The activities of these enzymes are regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs), and it has been suggested that a balance between MMPs and TIMPs plays an important role in vascular remodelling, angiogenesis and vasodilatation in a number of physiological situations. It follows that, regarding a relationship between MMPs and TIMPs, an imbalance between these molecules may lead to pathology in a wide range of conditions, including hypertension, cancer and pulmonary disease, and in the pathophysiology of reproduction. Indeed, regarding the latter, abnormalities in the maternal peripheral vasculature have been proposed as being (partly) responsible for the effects of hypertension on pregnancy and the development of complications including pre-eclampsia and eclampsia. However, the associations between MMPs, TIMPs and disease may be simply of association, not of pathology. This brief review explores current literature on the role of abnormalities of the ECM in general, focusing on the pathogenesis of hypertension and its complications during pregnancy as a model of disordered angiogenesis and remodelling.Journal of Human Hypertension advance online publication, 15 March 2012; doi:10.1038/jhh.2012.8.
Original languageEnglish
JournalJournal of Human Hypertension
Publication statusPublished - 15 Mar 2012


Dive into the research topics of 'Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.'. Together they form a unique fingerprint.

Cite this